Technology | Flat Panel Displays | November 02, 2016

Sharpness Recovery technology restores image quality typically lost with increased monitor brightness

Eizo, RadiForce GX550 medical monitor, FDA approval, digital breast tomosynthesis, DBT, mammography, RSNA 2016

November 2, 2016 — Eizo Inc. announced the release of the RadiForce GX550, a 21.3-inch, 5 megapixel monitor for viewing detailed digital breast tomosynthesis and mammography images. It is the successor model to the RadiForce GX540 and features superior imaging capability and ease-of-use.

A medical monitor needs to be capable of high brightness in order to meet performance standards. However, in order to achieve high brightness in an LCD panel, the pixel aperture ratio has to be increased. This causes a typically unavoidable decline in sharpness. The RadiForce GX550 features Eizo’s Sharpness Recovery technology, with which the decrease in sharpness (MTF) is restored. This allows healthcare professionals to display an image safely on the monitor that is true to the original source data, even at high brightness levels.

The monitor’s new design features thinner, black front bezels, making it easier to focus on images in dark reading rooms, while the original white stripe design around the sides of the monitor presents a fresh, clean aesthetic to promote a comfortable, user-friendly environment. For keeping the workspace efficient, the monitor’s width, height and depth were reduced by 21 mm, 36 mm and 45.5 mm respectively – a 28 percent difference compared to its predecessor. The width of the side bezels was reduced by approximately half to 13.5 mm – the thinnest in the industry for 5 megapixel monitors, according to Eizo. This allows users to comfortably view two monitors side by side to compare images.

The company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for digital breast tomosynthesis and digital mammography for the RadiForce GX550. Digital breast tomosynthesis is a method of breast screening that allows the radiologist to view detailed three-dimensional images of the breast assembled from multiple X-ray pictures. When used in combination with digital mammography, tomosynthesis provides radiologists with multiple screening techniques that can be utilized together for increased diagnostic precision in breast cancer detection.

Eizo will be showing the RadiForce GX550 at the 2016 Radiological Society of North America annual meeting (RSNA 2016), Nov. 27-Dec. 1 in Chicago.

The new monitor will begin shipping in December.

For more information: www.eizo.com


Related Content

News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
Subscribe Now